Skip to content
InMed-logo-01
  • Science
    • INM-755 for Epidermolysis Bullosa
    • INM-088 for Glaucoma
    • IntegraSyn™ Cannabinoid Manufacturing
    • InMed’s Research of Rare Cannabinoids
  • Investor
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Governance
    • Partners and Collaborators
    • Events Calendar
    • Careers
  • Learn
    • What is Cannabinol (CBN)?
    • What is Epidermolysis Bullosa (EB)?
    • What is Glaucoma?
    • GMP Manufacturing Standards by Product Type
    • Cannabis Treatments for Glaucoma
    • Cannabinoid Science
    • Articles and Videos
  • Contact
Menu
  • Science
    • INM-755 for Epidermolysis Bullosa
    • INM-088 for Glaucoma
    • IntegraSyn™ Cannabinoid Manufacturing
    • InMed’s Research of Rare Cannabinoids
  • Investor
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Governance
    • Partners and Collaborators
    • Events Calendar
    • Careers
  • Learn
    • What is Cannabinol (CBN)?
    • What is Epidermolysis Bullosa (EB)?
    • What is Glaucoma?
    • GMP Manufacturing Standards by Product Type
    • Cannabis Treatments for Glaucoma
    • Cannabinoid Science
    • Articles and Videos
  • Contact
TSX_Logo
NASDAQ_Logo

InMed Conferences and Events

Edison Open House: Global Conference 2021

Date: January 26-28, 2021

Conference website: https://www.edisongroup.com/event/open-house-global-healthcare-2021/

Presentation details:  InMed’s CEO Eric A. Adams to present Thursday, January 28th at 1:30pm GMT / 8:30am EST. Presentation information available here.

 

For 1×1 meetings, please reach out to Laine Yonker at [email protected].

Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe

Date: January 19-21, 2021

Conference website: https://cdp-europe.com/

Panel participation details:

InMed’s Michael Woudenberg – Vice President, Chemistry, Manufacturing & Controls, Karen Long – Senior Director, Drug Development, and Prof. Mauro Maccarrone PhD – Scientific Advisor to InMed will all be featured as expert speakers at the event.

Mr. Michael Woudenberg will participate on the panel discussion “Comparing Whole Plant & Synthetic Cannabinoids & Their Potential in Pharmaceuticals” on January 20, 2021 at 12:00pm GMT.

Ms. Karen Long will participate on the panel discussion “The Industry Approach to Gaining Drug Approval” on January 20, 2021 at 2:30pm GMT.

In addition, Prof. Mauro Maccarrone, a member of InMed’s Scientific Advisory Board, will speak in a lecture entitled “Plant-Derived & Endogenous Cannabinoids: Naturally Different”.

Read press release

BIO Partnering at JPM

InMed Pharmaceuticals participating in 1×1 meetings at BIO Partnering at JPM.

Date: January 11-15, 2021

Conference Website: https://www.bio.org/events/bio-partnering-jpm/

For 1×1 meetings, please reach out to [email protected].

H. C. Wainwright BioConnect 2021

InMed CEO Eric A. Adams to present at H. C. Wainwright BioConnect 2021.

Date: January 11-14, 2021

Conference Website: www.hcwevents.com/bioconnect.

Presentation Details: The company presentation by Eric A. Adams, President and CEO of InMed, will be available on demand beginning January 11th at 6am EST and can be found at the below link. The presentation will be archived for 90 days following the conclusion of the event. Presentation Link: https://journey.ct.events/view/a48c3f9e-1802-4279-95ca-eff84fafe024


INM-755

A cannabinol (CBN) cream under development for the treatment for Epidermolysis Bullosa
Learn More

INM-088

For the Treatment of Glaucoma
Learn More
InMed-logo-mono
#310 – 815 West Hastings St.
Vancouver, BC, Canada
V6C 1B4
Science
  • INM-755 for Epidermolysis Bullosa
  • INM-088 for Glaucoma
  • IntegraSyn™ Cannabinoid Manufacturing
  • InMed’s Research of Rare Cannabinoids

Investor

  • News Releases
  • Latest Presentation
  • Letter to Shareholders
  • SEDAR® Filings
  • Financial Reports
  • Sign up for Investor Alerts

About

  • Management
  • Board of Directors
  • Scientific Advisory Board
  • Corporate Governance
  • Partners and Collaborators
  • Events Calendar
  • Careers

Learn

  • What is Cannabinol (CBN)?
  • What is Epidermolysis Bullosa (EB)?
  • What is Glaucoma?
  • GMP Manufacturing Standards by Product Type
  • Cannabinoids for Glaucoma
  • Cannabinoid Science
  • Articles and Videos

© Copyright 2021 InMed Pharmaceuticals Inc.

  • Privacy Policy
  • Terms of Use
  • Legal Disclaimer
  • Find Us On: